3,214
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Upconverting Nanoparticles as Nanotransducers for Photodynamic Therapy in Cancer Cells

&
Pages 73-82 | Published online: 30 Jan 2008

Bibliography

  • Hopper C , NiziolC, SidhuM: The cost–effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK.Oral Oncol.40, 372–382 (2004).
  • Hur C , NishiokaNS, GazelleGS: Cost–effectiveness of photodynamic therapy for treatment of Barrett‘s esophagus with high grade dysplasia.Dig. Dis. Sci.48, 1273–1283 (2003).
  • Grant WE , SpeightPM, HopperC, BownSG: Photodynamic therapy: an effective, but non-selective treatment for superficial cancers of the oral cavity.Int. J. Cancer71, 937–942 (1997).
  • Kato H : Photodynamic therapy for lung cancer – a review of 19 years’ experience.J. Photochem. Photobiol. B42, 96–99 (1998).
  • Skyrme RJ , FrenchAJ, DattaSN, AllmanR, MasonMD, MatthewsPN: A Phase 1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma.BJU Int.95, 1206–1210 (2005).
  • Schuller DE , McCaughanJS Jr, Rock RP: Photodynamic therapy in head and neck cancer. Arch. Otolaryngol.111, 351–355 (1985).
  • Rhodes LE , de Rie M, Enstrom Y et al.: Photodynamic therapy using topical methyl aminolevulinate vs surgery for nodular basal cell carcinoma: results of a multicenter randomized prospective trial. Arch. Dermatol.140, 17–23 (2004).
  • Gao D , AgayanRR, XuH, PhilbertMA, KopelmanR: Nanoparticles for two-photon photodynamic therapy in living cells.Nano Lett.6, 2383–2386 (2006).
  • Pires AM , HeerS, GudelHU, SerraOA: Er, Yb doped yttrium based nanosized phosphors: particle size, “host lattice” and doping ion concentration effects on upconversion efficiency.J. Fluoresc.16, 461–468 (2006).
  • Zhang P , RogeljS, NguyenK, WheelerD: Design of a highly sensitive and specific nucleotide sensor based on photon upconverting particles.J. Am. Chem. Soc.128, 12410–12411 (2006).
  • Heer S , KompeK, GudelHU, HaaseM: Highly efficient multicolour upconversion emission in transparent colloids of lanthanide-doped NaYF4 nanocrystals.Adv. Mater.16, 2102–2105 (2004).
  • Zhang P , SteelantW, KumarM, ScholfieldM: Versatile photosensitizers for photodynamic therapy at infrared excitation.J. Am. Chem. Soc.129, 4526–4527 (2007).
  • Wang F , ChatterjeeDK, LiZ, ZhangY, FanX, WangM: Synthesis of polyethylenimine/NaYF4 nanoparticles with upconversion fluorescence.Nanotechnology17, 5786 (2006).
  • Wieder ME , HoneDC, CookMJ, HandsleyMM, GavrilovicJ, RussellDA: Intracellular photodynamic therapy with photosensitizer-nanoparticle conjugates: cancer therapy using a ‘Trojan horse‘.Photochem. Photobiol. Sci.5, 727–734 (2006).
  • Ricci-Junior E , MarchettiJM: Preparation, characterization, photocytotoxicity assay of PLGA nanoparticles containing zinc (II) phthalocyanine for photodynamic therapy use.J. Microencapsul.23, 523–538 (2006).
  • Chatterjee DK , ZhangY: Upconversion fluorescence imaging of cells and small animals using lanthanide doped nanocrystals.Biomaterials29(7), 937–943 (2008).
  • Star WM : Light dosimetry in vivo.Phys. Med. Biol.42, 763–787 (1997).
  • Hatz S , LambertJD, OgilbyPR: Measuring the lifetime of singlet oxygen in a single cell: addressing the issue of cell viability.Photochem. Photobiol. Sci.6, 1106–1116 (2007).
  • Weitman SD , FrazierKM, KamenBA: The folate receptor in central nervous system malignancies of childhood.J. Neurooncol.21, 107–112 (1994).
  • Weitman SD , LarkRH, ConeyLRet al.: Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.Cancer Res.52, 3396–3401 (1992).
  • Weitman SD , WeinbergAG, ConeyLR, ZurawskiVR, JenningsDS, KamenBA: Cellular localization of the folate receptor: potential role in drug toxicity and folate homeostasis.Cancer Res.52, 6708–6711 (1992).
  • de Nonancourt-Didion M , GueantJL, AdjallaC, CheryC, HatierR, NamourF: Overexpression of folate binding protein α is one of the mechanism explaining the adaptation of HT29 cells to high concentration of methotrexate.Cancer Lett.171, 139–145 (2001).
  • Vogel A , VenugopalanV: Mechanisms of pulsed laser ablation of biological tissues.Chem. Rev.103, 577–644 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.